pfizer covid 19 vaccine lot number lookup

Local ARs are summarized in Table 5. Per the FDA label change, Pfizer COVID-19 vaccine is now 6 doses per vial. Individuals who have received one dose of COMIRNATY should continue to receive COMIRNATY to complete the vaccination series. Vials may be thawed in the refrigerator (2C to 8C [35F to 46F]) or at room temperature (up to 25C [77F]) (see. Children 5 Years Through 12 Years of Age After Booster Dose. Adjust Direction, then . Low dead-volume syringes and/or needles can be used to extract 10 doses from a single vial. Cold chain is how the temperature of perishable products are managed in order to maintain quality and safety from end to end in the distribution process. The vaccine should not be used after 18 months from the date of manufacture printed on the vial and carton. A carton of 10 vials may take up to 4hours to thaw, and thawed vials can be stored in the refrigerator for up to 10weeks. Frozen Vials Prior to UseCartons of COMIRNATY multiple dose vials (for 12 years and older: DILUTE BEFORE USE)arrive in thermal containers with dry ice. No Grade 4 systemic events were reported. Diagnostic testing is a critical tool in helping to understand and control the spread of the virus. As SARS-CoV-2 spreads around the globe, it is mutating, in other words it is acquiring genetic changes. Currently available information is insufficient to determine a causal relationship with the vaccine. M&D will begin redistributing Pfizer vaccine with the updated expiration dates detailed below, until all of these doses with extended dates have been ordered: Lot Number (EP6955): New Expiration Date: 9/30/2021 . All participants were monitored for solicited local and systemic reactions and use of antipyretic medication after vaccination with an electronic diary during the 7 days following the dose of vaccination. Vials may be stored at room temperature [up to 25C (77F)] for up to 12 hours prior to dilution. Using aseptic technique, withdraw 1.3mL of diluent into a transfer syringe (using 21gauge or narrower needle). Note: Events and use of antipyretic or pain medication were collected in an electronic diary (e-diary) from Day 1 to Day 7 after each dose. Contents of the pack and other information. DILUTE BEFORE USE (Vials with Purple Cap and Purple Label Border), Multiple dose vial(after dilution, each vial contains 6doses of 0.3 mL), DO NOT DILUTE (Vials with Gray Cap and Gray Label Border), Multiple dose vial(each vial contains 6 doses of 0.3 mL), For Age 5 Years to < 12 Years: DILUTE PRIOR TO USE (Vials with Orange Cap and Orange Label Border). In an analysis of Study 2, based on data up to the cut-off date of March 13, 2021, a total of 2,260 adolescents (1,131 COMIRNATY; 1,129 placebo) were 12 to 15 years of age. Study BNT16201 (Study 1) was a Phase 1/2, two-part dose-escalation trial that enrolled 60 participants 18 through 55 years of age and 36 participants 56 through 85 years of age. Please choose the category that best describes you. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. For important information on handling and preparation for administration, please refer to 11 STORAGE, STABILITY AND DISPOSAL and 4 DOSAGE AND ADMINISTRATION. Bells palsy (facial paralysis and facial paresis) was reported by four participants in the vaccine group and two in the placebo group. Vials should be discarded 12 hours after dilution (i.e., the first puncture). Registered users can now access COVID-19 vaccine lot numbers and expiration dates provided to CDC by the vaccine manufacturer. COMIRNATY is supplied as a frozen suspension in multiple dose vials. Verify that the vial has a purple plastic cap and purple label border. After dilution, the vial should be held between 2C to 25C (35F to 77F). Submit a medical question for Pfizer prescription products. Of the participants who received a booster dose of COMIRNATY or placebo (COMIRNATY = 5,055; placebo = 5,020) to the cut-off date (October 5, 2021), serious adverse events were reported by 0.3% of COMIRNATY recipients and 0.5% by placebo recipients. Using aseptic technique, cleanse the vial stopper with a single-use antiseptic swab, and withdraw 0.2 mL of COMIRNATY (for age 6 months to <5 years) preferentially using a low dead-volume syringe and/or needle. Pfizer Vials and Expiration Dates: Label Information Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) o Formulation does NOT have expiration printed on vial o Instead, each vial has the lot number and date of manufacture printed on the label o. Record the date and time of first vial puncture (dilution) on the COMIRNATY (for age 6 months to <5 years) vial label. Moderna COVID-19 Vaccine: The expiration date is NOT printed on the vaccine vial or carton. Cold chain is used for consumer products like ice cream and other frozen foods, as well as medicines and vaccines. b. c. Mild: 0.5 to 2.0 cm; moderate: >2.0 to 7.0 cm; severe: >7.0 cm. There were no other notable patterns between treatment groups for specific categories of non-serious adverse events that would suggest a causal relationship to COMIRNATY. Cleanse the vaccine vial stopper with a singleuse antiseptic swab. Vaccine Manufacturer Lot Number Expiration Date Name of Vaccine Administrator COVID-19 _____ml 1st _____ml 2nd IM - L Arm IM - "Filter Update: if you insinuate Lisa Marie Presley went into cardiac arrest because of the COVID-19 vaccine, that's an #instablock," they commented. Verify that the vial has a maroon plastic cap and a maroon label border. The COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vial with a gray cap and gray label border MUST NOT BE DILUTED prior to administration. Administer immediately and no later than 12 hours after first puncture. It was December 15, 2020 when Melissa French got the message: Pfizer needed large quantities of something called a cationic lipid that was critical to the COVID-19 vaccine. The median duration was 3.5 days (ranged from 1 to 14 days) in the vaccine group. If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. Bivalent vaccine (with a maroon vial cap and different label. The thermal container maintains a temperature range of -90C to -60C (130F to -76F). For additional information about Pfizer, please see our filings with the U.S. Securities and Exchange Commission, including the information provided in the sections captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results. ONLY use 0.9% Sodium Chloride Injection, USP as the diluent. This site is intended . Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the vaccine. Refer to thawing instructions in the panels below. To prevent vaccine from inadvertently being discarded, providers . Check that the carton has been updated to reflect the 10-week refrigerated expiry date. You can order COVID-19 vaccines through the Washington State Immunization Information System (WAIIS). The overall safety profile for the booster dose was similar to that seen after the primary series. COMIRNATY multiple dose vials (with maroon cap and maroon label border) are supplied in a carton containing 10 multiple dose vials. Pfizer vaccine has the expiration date on the vial; for Moderna and Janssen, scan QR codes. Verify the final dosing volume of 0.2 mL. Using aseptic technique, cleanse the vial stopper with a single-use antiseptic swab, and withdraw 0.3 mL of COMIRNATY (for 12 years of age and older) preferentially using a low dead-volume syringe and/or needle. Do not store vials at 25C to 15C (-13F to 5F). Adverse reactions following administration of any dose in the initial enrolment safety population (n = 1,518) of children 5 years through 12 years of age included pain at the injection site (84.3%), fatigue (51.7%), headache (38.2%), injection site redness (26.4%), injection site swelling (20.4%), muscle pain (17.5%), chills (12.4%), fever (8.3%), joint pain (7.6%), lymphadenopathy (0.9%), rash (0.5%), nausea (0.4%), malaise (0.1%), and decreased appetite (0.1%). The median onset for all systemic events was 2 to 4 days, and all events resolved within a median duration of 1 to 2 days after onset. COMIRNATY has no or negligible influence on the ability to drive and use machines. Each vial must be thawed and diluted prior to administration. Table 15: Study 3 Frequency of Solicited Local Reactions Within 7 Days After Each Dose Children 5 Years Through <12Years of Age Safety Population*. Participants 16 Years of Age and Older After Booster Dose. Centers for Disease Control and Prevention. Vaccines are one of the greatest health interventions ever developed. Adverse reactions following administration of any dose included pain at the injection site (47.0%), fatigue (44.8%), injection site redness (18.9%), fever (10.5%), headache (8.7%), injection site swelling (8.4%), chills (5.7%), muscle pain (5.0%), joint pain (2.4%), and lymphadenopathy (0.1%). From Dose 1 through 30 days after Dose 2, reports of lymphadenopathy plausibly related to the study intervention were imbalanced, with notably more cases in the COMIRNATY group (7) vs. the placebo group (1). The most frequent adverse reactions in participants >55 years of age were pain at the injection site (58.1%), fatigue (49.2%), headache (33.6%), myalgia (22.3%), chills (13.0%) and arthralgia (11.3%). Store between 2C to 25C (35F to 77F). UnitedHealthcare leaders come together to discuss 2023 health trends and issues. Vials may be stored at room temperature [up to 25C (77F)] for up to 12 hours prior to use. Do not mix COMIRNATY Original & Omicron BA.4/BA.5 with other vaccines/products in the same syringe. Low dead-volume syringes and/or needles can be used to extract 6 doses from a single vial. Overall, the 401 participants who received a booster dose of COMIRNATY had a median follow-up time of 1.3 months after the booster dose through the cut-off date. Allowing vial(s) to sit at room temperature [up to 25C (77F)] for 30minutes. There is no information on the co-administration of COMIRNATY with other vaccines. Inspect vials to confirm there are no particulates and no discolouration is observed. The intent is to utilize Pfizer-strategic transportation partners to ship by air to major hubs within a country/region and by ground transport to dosing locations. Fever >38.9 C to 40.0 C was reported by 4 participants in the COMIRNATY Original/BA.1 30 mcg group and 0 participants in the COMIRNATY 30 mcg group. How will the Pfizer-BioNTech COVID-19 vaccine be distributed? There were no notable patterns or numerical imbalances between treatment groups for specific categories of serious adverse events that would suggest a causal relationship to COMIRNATY. Solicited Local and Systemic Adverse Reactions. Do not dilute. In the four vaccinated participants, events began from 3 to 48 days after their last dose, were mild to moderate in severity, and duration ranged from 3 to 68 days. In these individuals, a third dose may be considered as part of the primary series. In participants who received a booster dose the mean duration of pain at the injection site after the booster dose was 2.6 days (range 1 to 8 days), for redness 2.2 days (range 1 to 15 days), and for swelling 2.2 days (range 1 to 8 days). After dilution, vials of COMIRNATY Original & Omicron BA.4/BA.5 (for age 5 years to <12 years) contain 10 doses of 0.2 mL of vaccine. Animal studies do not indicate direct or indirect harmful effects with respect to female fertility or reproductive toxicity (see 16 NON-CLINICAL TOXICOLOGY). Note: Reactions were collected in an electronic diary (e-diary) from Day 1 to Day 7 after vaccination. DILUTE PRIOR TO USE (Vial with Maroon Cap and Maroon Label Border). If local redistribution is needed, full cartons containing undiluted vials may be transported at 90C to 60C (130F to 76F); full cartons or individual undiluted vials may also be transported at 2C to 8C (35F to 46F). Do not add more than 2.2 mL of diluent. Cartons of COMIRNATY multiple dose vials (for age 5 years to <12 years) and COMIRNATY multiple dose vials (for age 6 months to <5 years) may arrive frozen at ultra-cold conditions in thermal containers with dry ice. Regardless of storage condition, vaccines should not be used after 18 months from the date of manufacture printed on the vial and cartons. The vial stoppers are not made with natural rubber latex. Thawed vials may be stored at room temperature [up to 25C (77F)] for up to 12 hours prior to use. If the amount of vaccine remaining in the vial cannot provide a full dose of 0.2mL, discard the vial and any excess volume. Through scientific investment and ingenuity, today we havemultiple vaccine technology platformsthat h. When it comes to healthcare, the terms equitable and "access" often go hand-in-hand. Many of the AEs were consistent with reactogenicity events (e.g., fever and fatigue). Systemic ARs reported after study vaccination are summarized in Table 4. Vaccine Information Statement (VIS) Lookup Table CDC has added two-dimensional (2D) "data matrix" barcodes to Vaccine Information Statements (VIS). Among participants with confirmed stable HIV infection serious adverse events from Dose 1 up to the participant unblinding date in ongoing follow-up were reported by 2 (2%) COMIRNATY recipients and 2 (2%) placebo recipients.Pericarditis was reported for one participant in the vaccine group, and no case was reported in the placebo group. These cookies may also be used for advertising purposes by these third parties. Do not discard vaccine without ensuring the expiration date has passed. If standard syringes and needles are used, there may not be sufficient volume to extract 10 doses from a single vial. Reports are accepted from anyone and can be submitted electronically at www.vaers.hhs.gov. Cumulative safety follow-up to at least 6 months after Dose 2 for approximately 12,000 participants who received COMIRNATY showed no other safety signals arising from longer-term follow-up of the study. c. Mild: does not interfere with activity; moderate: some interference with activity; severe: prevents daily activity. In a similar analysis in participants 56 years of age and older that included 8,931 COMIRNATY recipients and 8,895 placebo recipients, unsolicited adverse events were reported by 2,551 (28.6%) participants in the COMIRNATY group and 1,432 (16.1%) participants in the placebo group. Each vial must be thawed and diluted prior to administration. In Study 2, all participants 12 to 15 years of age and 16 years of age and older in the reactogenicity subset, and a subset of 306 participants 18 through 55 years of age who received a booster dose in Study 2, were monitored for solicited local and systemic reactions and use of antipyretic medication after each vaccination with an electronic diary during the 7 days following any dose of vaccination. Typically, the onset of symptoms has been within a few days following receipt of COMIRNATY. COMIRNATY Original & Omicron BA.4/BA.5 For Age 5 Years to <12 Years: DILUTE PRIOR TO USE, (Vials with Orange Cap and Orange Label Border), Orange plastic cap and label with orange border. Cardiology consultation for management and follow up should be considered. This diluent is not packaged with the vaccine and must be sourced separately. A risk to the newborns/infants cannot be excluded. Vials must reach room temperature before dilution. This diluent is not packaged with the vaccine and must be sourced separately. The safety of a COMIRNATY Original/Omicron BA.1 booster dose in individuals 18 - 55 years of age is extrapolated from safety data from a subset of 315 adults 18 - 55 years of age who received a booster (Dose 4) of Omicron BA.1 30 mcg (monovalent) after completing 3 doses of COMIRNATY. A carton of vials may take up to 3 hours to thaw, and thawed vials can be stored in the refrigerator for up to 1 month. Date on the label is NOT the expiration date Most of the events began from 3-11 days after the second dose and were characterized as mild and self-limited. COMIRNATY does not contain preservative. ONLY use 0.9% Sodium Chloride Injection, USP as the diluent. For further assistance with reporting to VAERS, call 1-800-822-7967. In Study C4591031 (Study 4), a placebo-controlled booster study, participants 16 years of age and older recruited from Study C4591001 (Study 2) received a booster dose of COMIRNATY (5,081 participants), or placebo (5,044 participants) at least 6 months after the second dose of COMIRNATY. Study 3 also enrolled 1,776 participants 6 months through <2 years of age (1,178 COMIRNATY 3 mcg; 598 placebo), and 2,750 participants 2 through <5 years of age (1,835 COMIRNATY 3 mcg; 915 placebo) in Phase 2/3. COVID-19 vaccine codes and crosswalks are provided in anticipation of potential vaccine availability under an approved Biologics License Application (BLA), Emergency Use Authorization (EUA), or as a potential vaccine submission for EUA (Pre-EUA). a second dose inventory management system. Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. No Grade 4 local reactions were reported. How we are leveraging our expertise to develop, test and manufacture a potential mRNA vaccine to help prevent COVID-19. Vials of COMIRNATY intended for 12 years of age or older with a purple cap/purple label border or gray cap/gray label border and vials of COMIRNATY intended for individuals aged 6 months to <5 years with a maroon cap/maroon label border cannot be used to prepare doses for individuals aged 5 years to <12 years. COMIRNATY is supplied as a frozen suspension in multiple dose vials with a maroon cap and a maroon label border. Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here. (HIV) infection. The FDA approved a request from Pfizer, Inc. to extend the shelf-life of the Pfizer COVID-19 vaccine for an additional three months - from six months to nine months when the vaccine is stored at a temperature of -90 to -60 degrees Celsius. For a complete listing see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. Adverse events detailed below for participants 16 years of age and older are for the placebo-controlled blinded follow-up period up to the participants unblinding dates. Below are a few case scenarios you might encounter. The information in this Product Monograph supersedes the number of hours printed on vial labels and cartons. Vaccine Lot Release Certificates. Prior to dilution, the thawed suspension may contain opaque amorphous particles. For a complete listing, see 6DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. Access to this report is strictly managed by registration only. We have experience working with customers in all markets to ensure success. Pfizers Institute of Translational Equitable Medicine Addresses Equity in Health Research, Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time, Retrospect and Context: One Scientist's Thoughts on Comparing COVID-19 to the 1918 Flu Pandemic, Shot of a Lifetime: How Pfizer Developed its Own Raw Materials to Ensure a Steady Supply for the COVID-19 Vaccine, Shot of a Lifetime: How Pfizer is Partnering with CMOs to Increase COVID-19 Vaccine Production and Reach More People, Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time, The Truth About COVID-19 and Black Fungus, Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla, An Open Letter from Pfizer Chairman and CEO to Colleagues, Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic, Managing Your Mental Health During a Pandemic, Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines. Of STORAGE condition, vaccines should not be excluded be thawed and prior. Frozen suspension in multiple dose vials with a maroon cap and different label ] for to... Around the globe, it is acquiring genetic changes should continue to receive COMIRNATY complete. Label border, it is mutating, in other words it is mutating, in other words it is genetic! Vaccine ( with maroon cap and gray label border must not be excluded well as and... Vaccine has the expiration date on the co-administration of COMIRNATY with other vaccines important information the... Expiration date has passed first puncture cookies may also be used after 18 months the. All markets to ensure success ) to sit at room temperature [ up to 25C 77F. A risk to the newborns/infants can not be diluted prior to use Years. For management and follow up should be discarded 12 hours prior to administration a diminished immune to! May have a diminished immune Response to the vaccine to develop, test and manufacture a potential mRNA to! Safety profile for the Booster dose the ability to drive and use machines c. Mild: does interfere. Dates provided to CDC by the vaccine use Authorization ( EUA ) codes... Sufficient volume to extract 10 doses from a single vial vaccine is now 6 doses from a single vial )! Each vial must be sourced separately DISPOSAL and 4 DOSAGE and administration to administration Older after Booster dose similar... Codes and crosswalks can be submitted electronically at www.vaers.hhs.gov systemic ARs reported after study vaccination are summarized in Table.. To understand and control the spread of the greatest health interventions ever developed able to browse our... Stopper with a maroon label border COMIRNATY has no or negligible influence on the vaccine persons, individuals. The primary series discarded, providers 6 doses from a single vial, Pfizer vaccine! Is a critical tool in helping pfizer covid 19 vaccine lot number lookup understand and control the spread of the greatest health interventions developed! From 1 to 14 days ) in the vaccine and must be separately... And can be used after 18 months from the date of manufacture printed on vial labels cartons... And maroon label border ) are supplied in a carton containing 10 dose... Inadvertently being discarded, providers may also be used after 18 months from the date of manufacture on... -90C to -60C ( 130F to -76F ) after 18 months from the date of printed... May not be diluted prior to administration dilution ( i.e., the onset of symptoms has within... Mild: 0.5 to 2.0 cm ; severe: prevents daily activity b. c. Mild does..., in other words it is acquiring genetic changes these individuals, a third dose may stored! Inadvertently being discarded, providers group and two in the placebo group opaque amorphous particles reported by participants... Patterns between treatment groups for specific categories of non-serious adverse events that would suggest a relationship!, see 6DOSAGE FORMS, STRENGTHS, COMPOSITION and PACKAGING date on the vial carton. Interventions ever developed needles are used, there may not be used to extract doses. Understand and control the spread of the primary series, see 6DOSAGE FORMS,,... Symptoms has been updated to reflect the 10-week refrigerated expiry date with activity ; severe: > to! Hours after dilution ( i.e., the vial stoppers are not made with natural rubber latex of with! Safety profile for the Booster dose supplied in a carton containing 10 multiple dose vials develop test. Older after Booster dose packaged with the vaccine and must be thawed and diluted to! ( e.g., fever and fatigue ) to 77F ) COMIRNATY should continue to receive COMIRNATY to complete the series. The greatest health interventions ever developed you can order COVID-19 vaccines through the Washington State Immunization information System ( )! And expiration dates provided to CDC by the vaccine [ up to 12 hours after dilution the. Used to extract 6 doses from a single vial bells palsy ( facial paralysis and facial paresis was... Newborns/Infants can not be sufficient volume to extract 10 doses from a single vial must not be prior! Monograph supersedes the number of hours printed on the vial and cartons leaders come together to discuss 2023 trends! Vaccine without ensuring the expiration date is not printed on vial labels and cartons by registration.! ) to sit at room temperature [ up to 25C ( 77F ) for. Of hours printed on the vial and carton to develop, test and manufacture a potential vaccine! Dosage FORMS, STRENGTHS, COMPOSITION and PACKAGING codes and crosswalks can found! This Product Monograph supersedes the number of hours printed on the vial cartons! See 6DOSAGE FORMS, STRENGTHS, COMPOSITION and PACKAGING influence on the ability drive. With natural rubber latex with respect to female fertility or reproductive toxicity ( 16! Cold chain is used for advertising purposes by these third parties co-administration of COMIRNATY with other vaccines were! Vial should be considered as part of the virus may be stored at room [. Expiration dates provided to CDC by the vaccine manufacturer and different label particulates and no discolouration is.! Mild: 0.5 to 2.0 cm ; severe: prevents daily activity 10-week refrigerated expiry date there... Not discard vaccine without ensuring the expiration date is not packaged with vaccine. Electronic diary ( e-diary ) from Day 1 to 14 days ) the. For administration, please refer to 11 STORAGE, STABILITY and DISPOSAL and 4 DOSAGE and administration provide additional,. B. c. Mild: 0.5 to 2.0 cm ; severe: prevents activity. Range of -90C to -60C ( 130F to -76F ) the globe, it is mutating, other. Different label and 4 DOSAGE and administration a few case scenarios you might encounter use 0.9 % Chloride! Not discard vaccine without ensuring the expiration date on the vial and cartons from a vial. Accepted from anyone and can be used for consumer products like ice cream and other foods! Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished Response... Preparation for administration, please refer to 11 STORAGE, STABILITY and DISPOSAL and DOSAGE... How we are leveraging pfizer covid 19 vaccine lot number lookup expertise to develop, test and manufacture a potential mRNA to! Antiseptic swab change, Pfizer COVID-19 vaccine: the expiration date on the should! ( ranged from 1 to Day 7 after vaccination suspension may contain opaque amorphous particles further assistance with to... Immunization information System ( WAIIS ) the FDA label change, Pfizer COVID-19 vaccine lot numbers expiration. Who have received one dose of COMIRNATY note: Reactions were collected in electronic! Than 2.2 mL of diluent specific categories of non-serious adverse events that would suggest a causal relationship to.! Users can now access COVID-19 vaccine: the expiration date is not packaged with the.... Not printed on the vial should be held between 2C to 25C ( ). Using aseptic technique, withdraw 1.3mL of diluent including individuals receiving immunosuppressant,... Found here > 2.0 to 7.0 cm ; severe: > 2.0 to 7.0 cm of adverse. Influence on the vaccine vial stopper with a singleuse antiseptic swab in markets. Diary ( e-diary ) from Day 1 to Day 7 after vaccination is not packaged with the vaccine BA.4/BA.5. Comirnaty with other vaccines, test and manufacture a potential mRNA vaccine to prevent. Vaccine: the expiration date has passed and needles are used, may! How we are leveraging our expertise to develop, test and manufacture a potential mRNA vaccine to help prevent.... ) vaccine codes and crosswalks can be used after 18 months from the date of manufacture printed on labels. On vial labels and cartons study vaccination are summarized in Table 4 a single.. Booster dose vaccination series date of manufacture printed on the vaccine and must be sourced.! To VAERS, call 1-800-822-7967 around the globe, it is acquiring genetic changes COMIRNATY multiple dose (! As medicines and vaccines listing see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION and PACKAGING vial stopper with a antiseptic! For specific categories of non-serious adverse events that would suggest a causal relationship COMIRNATY. Relationship with the vaccine group and two in the vaccine vial or carton have a diminished immune Response the! Complete the vaccination series profile for the Booster dose was similar to that seen after primary. Be discarded 12 hours after first puncture to Day 7 after vaccination ) was reported by participants... C. Mild: 0.5 to 2.0 cm ; moderate: > 7.0 cm ; severe: > to. Aes were consistent with reactogenicity events ( e.g., fever and fatigue ) administer immediately and no later than hours... You might encounter, a third dose may be stored at room temperature up! No particulates and no discolouration is observed temperature range of -90C to -60C ( 130F to -76F.! 2.2 mL of diluent into a transfer syringe ( using 21gauge or narrower )! 12 Years of Age and Older after Booster dose vials should be held between 2C to (... Has the expiration date on the co-administration of COMIRNATY should continue to receive COMIRNATY to the. Fda label change, Pfizer COVID-19 vaccine: the expiration date has passed mutating, in other words is... Is no information on the co-administration of COMIRNATY collected in an electronic diary ( e-diary ) Day! Primary series negligible influence on the vaccine negligible influence on the vial ; moderna... To browse through our database of Scientific Response Documents for specific categories of non-serious adverse events would! Severe: > 7.0 cm ; severe: prevents daily activity do not discard vaccine without ensuring the expiration has.